MEK1 (Ab 221) Antilichaam

Catalyzes the concomitant phosphorylation of a threonine and a tyrosine residue in a Thr-Glu-Tyr sequence located in MAP kinases. Activates ERK1 and ERK2 MAP kinases.

5604

Q02750

NP_002746.1

Human, Mouse, Rat

MEK1 (Ab-221) antibody was raised against a peptide sequence around aa.219~223 (A-N-S-F-V) derived from Human MEK1.

Unconjugated

Primary Antibodies

Other

Antibodies were purified by affinity-chromatography using epitope-specific peptide.

1 mg/mL

Antibody supplied in phosphate buffered saline (without Mg2+ and Ca2+), pH 7.4, 150mM NaCl, 0.02% sodium azide and 50% glycerol.

None

Blue Ice

Store antibody at -20˚ C for up to one year.

45 kDa

This antibody detects endogenous level of total MEK1 protein.

Western Blot: 1:500~1:1000, Immunohistochemistry: 1:50~1:100

MAP2K1

Mitogen-activated protein kinase kinase 1

Homo sapiens

Zebisch A, et al. (2006) Cancer Res; 66 (7) : 3401-8. Luciano BS, et al. (2006) J Biol Chem; 279 (50) : 52117-23. Wang X, et al. (2003) Oncogene; 22 (1) : 109-16. Gopalbhai K, et al. (2003) J Biol Chem; 278 (10) : 8118-25. Ling MT, et al. (2002) Oncogene; 21 (55) : 8498-505.

CFC3, MEK1, MKK1, MAPKK1, PRKMK1, JNKK1, MEK4, MKK4, PRKMK4, SEK1, SERK1, SKK1, ERK activator kinase 1, MAP kinase kinase 1, MAP2K1, MAPK/ERK kinase 1, MAPKK 1

WB, IHC

5579478

Liquid